Jinhai Medical Technology Limited (stock code: 02225) released its monthly return for the period ended 28 February 2026. The authorized share capital remains at 8.00 billion ordinary shares with a par value of HKD 0.0025 each, amounting to HKD 20.00 million in total. The total issued share count stays at 5.29 billion with no treasury shares, reflecting no change from the prior month.
The company confirms that its public float continues to meet a 25.00% requirement under relevant listing rules. Its share option scheme, adopted on 29 December 2023, holds 454.96 million outstanding share options without any new share issuances during the reporting period.
Comments